Company profile
PURPLE BIOTECH LTD.
NASDAQ:PPBTBiotechnology: Pharmaceutical Preparations
Drug pipeline (2)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| Amlodipine Besylate | approved | — | 11 | approved |
| Celecoxib | approved | — | 6 | approved |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| NDA 210045 | NDA | PURPLE BIOTECH LTD | ||||
Loading… | ||||||